Skip to main content
. 2006 Nov 30;579(Pt 1):203–213. doi: 10.1113/jphysiol.2006.123158

Figure 5. Effects of 5-HT3 receptor antagonism on serosal/mesenteric afferent responses to 5-HT (100 μm) in control and inflamed tissue.

Figure 5

Alosetron (200 nm) significantly reduced responses to 5-HT in controls (n = 5), whereas it had no significant effect in the inflamed group (n = 5).